Prot #PUMA-NER-5201: An Open-Label, Phase 2 Basket Study Of Neratinib In Patients With Solid Tumors With Somatic Activating HER Mutations

Project: Research project

Project Details

StatusActive
Effective start/end date5/9/185/9/21

Funding

  • Precision Oncology, LLC (Prot #PUMA-NER-5201)
  • Puma Biotechnology, Inc. (Prot #PUMA-NER-5201)